Plain-English translation of NCT07598617 on ClinicalTrials.gov ↗ ·
This trial is testing a new computerized cognitive assessment tool designed to detect very early signs of Alzheimer's disease. The study aims to evaluate whether this computer-based memory test is sensitive enough to catch the subtle cognitive changes that happen before dementia symptoms develop. The tool will be tested in people aged 65 and older who have noticed changes in their memory or thinking abilities.
Currently, most cognitive tests available in the NHS are not sensitive enough to detect the very early, subtle memory and thinking changes that occur in preclinical Alzheimer's disease. This study exists to develop and evaluate a better screening tool that, combined with blood biomarkers, could help doctors diagnose Alzheimer's disease earlier—potentially before dementia develops—so that new disease-slowing medications can be started sooner.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would take part in this research study focused on evaluating the new computerized memory assessment tool. You would complete the computer-based cognitive test, which is designed to be more sensitive to early memory changes than traditional tests. The study involves 120 participants with either subjective memory concerns or mild cognitive impairment, and you would be part of helping researchers understand whether this new tool is effective at detecting very early Alzheimer's disease.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United Kingdom